GGA-30339-43586
3 vaccinations
3 coded responses
12 check-ins
3 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 945 / CA
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2021-01-13
Dose 2 — Pfizer-BioNTech
-
2021-01-14
Registered in v-safe
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-15
Survey response — days 1–6 daily, dose 2MedDRA: Cold sweat, Feeling hot — Feeling: Good · Site: Pain · Fever · Fatigue or tirednessFree text: Feeling hot and clammyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-17
-
2021-01-22
Health check-in — day 7, dose 2Feeling: Fair · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-01-22
Report sent to call center — day 7, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-28
Survey response — day 14, dose 2MedDRA: Rash — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Yes have had a rash, potential drug eruption from vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Report sent to call center — day 14, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-03
-
2021-02-10
Survey response — day 28, dose 2MedDRA: Gastrointestinal disorder — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: GI issuesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-19
- 2021-02-24
- 2021-03-30
- 2021-06-08
-
2021-09-27
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-02
- 2021-10-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 unsuccessful
1 wait over 3 months for a first call
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Feeling hot and clammy
Release 2 — day 14, dose 2
Symptoms: Yes have had a rash, potential drug eruption from vaccine
Release 4 — day 28, dose 2
Symptoms: GI issues
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastrointestinal disorder | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SRO | Cold sweat | ✓ | ✓ | ✓ |
| SRO | Feeling hot | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release